Ning Lyu
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 27
- Cancer Research top 5%
- MicroRNA in disease regulation 5
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 7
- Pancreatic and Hepatic Oncology Research 6
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 12
-
- Liver Disease Diagnosis and Treatment 8
-
- Cancer, Stress, Anesthesia, and Immune Response 4
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- International Journal of Hyperthermia (3 papers)Journal of Vascular and Interventional Radiology (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ning Lyu
67 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Hepatology 488
- Cancer Research 459
- Oncology 352
- Pathology and Forensic Medicine 217
- Pulmonary and Respiratory Medicine 284
Countries citing papers authored by Ning Lyu
This map shows the geographic impact of Ning Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Lyu more than expected).
Fields of papers citing papers by Ning Lyu
This network shows the impact of papers produced by Ning Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Lyu. The network helps show where Ning Lyu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ning Lyu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 26 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 24 | |
| 14 | 2020 | 16 | |
| 15 | 2020 | 3 | |
| 16 | 2020 | 5 | |
| 17 | 2019 | 11 | |
| 18 | 2019 | 5 | |
| 19 | 2018 | 133 | |
| 20 | 2017 | 26 |
About Ning Lyu
Ning Lyu is a scholar working on Hepatology, Microbiology, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 70 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Liver Disease Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer Mechanisms and Therapy (6 papers), MicroRNA in disease regulation (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (4 papers). The work is most often cited by research in Hepatology (488 citations), Cancer Research (459 citations), Oncology (352 citations), Pathology and Forensic Medicine (217 citations) and Pulmonary and Respiratory Medicine (284 citations). Ning Lyu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ming Zhao, Haijing Deng, Shaolong Li, Qiankun Xie, Yanan Kong, Luwen Mu, Hailin Tang, Qifeng Chen, Zhenfeng Zhang and Jibin Li. Their work appears in journals such as International Journal of Hyperthermia, Journal of Vascular and Interventional Radiology, Scientific Reports, Liver Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.